Understanding UK’s Health Policy: Causes of Medicine Shortages
- There is a rising shortage of various drugs, including treatments for epilepsy, diabetes, cancer, heart diseases, and menopause in the UK. As of 18 December, 96 products were in short supply, rising from 52 in January 2022. Several factors have contributed to these shortages, including the impact of the war in Ukraine on supply chains, suspensions on certain medicines tested by an Indian lab, attacks on Red Sea shipping, and Brexit-related paperwork.
- A survey by Community Pharmacy England found that 92% of pharmacy teams were dealing with medicine supply issues daily, a rise from 67% the previous year. Furthermore, 87% of pharmacy teams fear that patient health is being compromised. Similar shortages have been reported across Europe, with 95% of hospital pharmacists experiencing scarcities.
- Besides global factors, there are issues unique to the UK contributing to these shortages. The value of the pound plummeted after the Brexit referendum, making it more costly for the National Health Service (NHS) to purchase medicines. Additionally, a voluntary government scheme aimed at controlling the expense of branded medicines has allegedly deterred drug manufacturers, leading to a 26% levy on revenues earned beyond a fixed cap. Lastly, inadequate planning and communication have exacerbated the issue, with pharmacy owners reporting aggression from patients due to supply problems.
UK Grapples with Shortages of Essential Drugs
A recent notification from the Department of Health and Social Care signals an impending shortage of Tegretol, an epilepsy medication. This carbamazepine 200mg prolonged-release tablet will be unavailable until mid-January. Recommendations to manage this shortage include resorting to low-risk therapeutic alternatives, importing unlicensed variants, or considering alternative strengths or formulations.
However, this drug shortage isn’t isolated. Last week, practitioners were informed of another potential supply problem with glucagon-like peptide-1 receptor agonists, medication used by those with type 2 diabetes. This posed a significant threat to patient safety, triggering national alerts.
Similarly, other vital medications, including those used for treating high blood calcium in cancer patients, menopause symptoms, heart-related chest pain, heart failure, oesophageal spasms, and angina, are also facing supply issues. These shortages have escalated fears among patients and healthcare professionals alike.
As of 18 December, the UK is dealing with shortages in 96 medication products, a slight decrease from the 111 shortages at the end of October. This figure is alarmingly higher than the 52 medicines which faced issues in January 2022.
Rising Concerns About Medicine Shortages
A 2023 pressure survey by Community Pharmacy England revealed that daily drug supply issues were affecting 92% of pharmacy teams, up from 67% last year. This dramatic increase has put patient health at risk, with 87% of pharmacy teams members believing so.
Furthermore, a recent European Association of Hospital Pharmacists survey highlighted that these medicine shortages aren’t restricted to the UK – 95% of hospital pharmacists across Europe are grappling with similar issues. Various factors have contributed to these shortages, including supply chain disruptions due to the Ukraine war, Red Sea shipping attacks and increased regulatory paperwork due to Brexit.
UK Specific Challenges
Unique challenges compound the UK’s drug shortage situation. The pound’s devaluation post-Brexit has led to increased medication costs for the NHS. Additionally, the government’s 2019 scheme to cap NHS spending on branded medicines has disincentivized drug manufacturers, resulting in reduced investment.
Besides, poor planning and communication have exacerbated the problem. The sudden hike in hormone replacement therapy prescriptions following the National Institute for Health and Care Excellence’s 2015 guidance led to unmet demand due to inadequate supply. The government’s penny-pinching approach, according to the British Generic Manufacturers Association, isn’t helping the situation.
These recurring medication shortages have frustrated patients and healthcare providers alike, leading to increased aggression towards pharmacists. Without a robust solution, patience with the system is fast depleting.
—
Read More Health & Wellness News ; US News
Leave a Comment